Quoin shareholders approve 12x authorized share increase and 1:60,000 reverse split

(1) The shareholders elected the following directors to serve on the Board of Directors, to serve until Quoin’s 2024 annual meeting of shareholders and until such director’s successor is duly elected and qualified, or until such director’s earlier resignation or retirement, as follows: Directors For Against Abstain Brokers non-vote Dr. Michael Myers 4,714,440,000 1,171,620,000 770,400,000 -- Denise Carter 5,738,640,000 707,160,000 210,660,000 -- Joseph Cooper 5,743,800,000 692,580,000 220,080,000 -- James Culverwell 5,720,880,000 715,140,000 220,440,000 -- Dr. Dennis H. Langer 5,345,160,000 1,115,640,000 195,660,000 -- Natalie Leong 5,754,360,000 694,500,000 207,600,000 -- Michael Sember 5,734,440,000 584,820,000 337,200,000 --

(10) The shareholders approved, on a non-binding advisory basis, the compensation of Quoin’s named executive officers, as follows: For Against Abstain Brokers non-vote 4,510,560,000 1,855,140,000 290,760,000 --

(2) The shareholders approved an amendment to Quoin’s Articles of Association, as amended (the “Articles of Association”), to increase the Company’s registered share capital from 500,000,000,000 ordinary shares, no par value, to 6,000,000,000,000 ordinary shares, no par value, as follows: For Against Abstain Brokers non-vote 4,338,900,000 2,218,020,000 99,540,000 --

(5) The shareholders approved an amendment to the terms of employment of Quoin’s Chief Operating Officer, as follows: For Against Abstain Brokers non-vote 4,655,340,000 1,847,220,000 153,900,000 --

(6) The shareholders approved an annual discretionary bonus under the terms of employment of Quoin’s Chief Executive Officer, as follows: For Against Abstain Brokers non-vote 1,929,840,000 1,678,440,000 29,100,000 --

(14) The shareholders approved the appointment of Marcum LLP as Quoin’s independent registered public accounting firm until Quoin’s 2024 annual meeting of shareholders, as follows: For Against Abstain Brokers non-vote 6,058,620,000 404,820,000 193,020,000 --

(4) The shareholders approved an amendment to the terms of employment of Quoin’s Chief Executive Officer, as follows: For Against Abstain Brokers non-vote 2,535,360,000 1,501,620,000 55,020,000 --

(9) The shareholders approved a grant of options to Quoin’s Chief Operating Officer, as follows: For Against Abstain Brokers non-vote 2,222,100,000 1,746,540,000 56,700,000 --

(11) The shareholders approved, on a non-binding advisory basis, the frequency of future advisory votes on the compensation of Quoin’s executive officers, as follows: 1Y 2 YR 3 YR Abstain Brokers non-vote 1,677,840,000 65,340,000 4,545,480,000 285,840,000 --

(7) The shareholders approved an annual discretionary bonus under the terms of employment of Quoin’s Chief Operating Officer, as follows: For Against Abstain Brokers non-vote 1,943,280,000 1,631,220,000 544,920,000 --

(8) The shareholders approved a grant of options to Quoin’s Chief Executive Officer, as follows: For Against Abstain Brokers non-vote 2,128,020,000 1,908,960,000 54,540,000 --

(3) The shareholders approved an amendment to Quoin’s Articles of Association to effect a reverse split of the Company’s ordinary shares at a ratio of 1-for-60,000, effective on a date to be determined by the Board of Directors of the Company, as follows: For Against Abstain Brokers non-vote 4,318,680,000 2,230,140,000 107,640,000 --